Diampa LXR (Empagliflozin+Linagliptin+Metformin) 12.5mg+2.5mg+1000mg, 14 Ct - Getz Pharma
Diampa LXR is a triple-combination oral therapy for the management of type 2 diabetes in adults. This specific formulation combines a higher 12.5mg dose of Empagliflozin (an SGLT2 inhibitor), a standard 2.5mg dose of Linagliptin (a DPP-4 inhibitor), and a full 1000mg dose of Metformin (a biguanide). It is designed for patients requiring intensive glucose-lowering effects with the added benefits of cardiovascular and renal protection from Empagliflozin, along with weight-neutral or weight-loss potential
- Enhanced Glucose Excretion: The higher 12.5mg Empagliflozin dose increases urinary glucose removal for stronger glycemic control.
- Heart & Kidney Benefits: Empagliflozin offers proven cardiovascular and renal protective advantages for eligible patients.
Composition
Each film-coated tablet contains:
- Empagliflozin: 12.5 mg
- Linagliptin: 2.5 mg
- Metformin HCI USP: 1000 mg
(as extended release)
Directions for Use
- As directed by the physician.
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Diampa LXR is a triple-combination oral therapy for the management of type 2 diabetes in adults. This specific formulation combines a higher 12.5mg dose of Empagliflozin (an SGLT2 inhibitor), a standard 2.5mg dose of Linagliptin (a DPP-4 inhibitor), and a full 1000mg dose of Metformin (a biguanide). It is designed for patients requiring intensive glucose-lowering effects with the added benefits of cardiovascular and renal protection from Empagliflozin, along with weight-neutral or weight-loss potential
- Enhanced Glucose Excretion: The higher 12.5mg Empagliflozin dose increases urinary glucose removal for stronger glycemic control.
- Heart & Kidney Benefits: Empagliflozin offers proven cardiovascular and renal protective advantages for eligible patients.
Composition
Each film-coated tablet contains:
- Empagliflozin: 12.5 mg
- Linagliptin: 2.5 mg
- Metformin HCI USP: 1000 mg
(as extended release)
Directions for Use
- As directed by the physician.
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
